Twist Bioscience (TWST) Surges 9.9%: Is This an Indication of Further Gains?

Twist Bioscience (TWST) shares soared 9.9% in the last trading session to close at $47.94. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 4.7% gain over the past four weeks.Last month, the company announced robust financial results for the fiscal fourth quarter and full-year fiscal 2024. This might have driven the share price rally.This maker of synthetic DNA for the biotechnology industry is expected to post quarterly loss of $0.62 per share in its upcoming report, which represents a year-over-year change of +17.3%. Revenues are expected to be $86.94 million, up 21.6% from the year-ago quarter.Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.For Twist Bioscience, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TWST going forward to see if this recent jump can turn into more strength down the road.The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Twist Bioscience is a member of the Zacks Medical - Biomedical and Genetics industry. One other stock in the same industry, Amgen (AMGN), finished the last trading session 0.8% higher at $263.38. AMGN has returned -9.9% over the past month.Amgen's consensus EPS estimate for the upcoming report has changed -1% over the past month to $4.97. Compared to the company's year-ago EPS, this represents a change of +5.5%. Amgen currently boasts a Zacks Rank of #3 (Hold).Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Twist Bioscience Corporation (TWST): Free Stock Analysis Report Amgen Inc. (AMGN): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks